• Trump To Sign Executive Order Promoting Artificial Intelligence

    The New York Times | President Trump is expected to sign an executive order meant to spur the development and regulation of AI. But the order does not set aside additional funds for AI development, and officials provided few details on how it will track the progress of its new policies.

    Feb 11, 2019
  • Clinical Genomics Insights In Hematological Malignancies Require Streamlined Bioinformatics Solutions

    Bio-IT World Contributed Commentary | Next-generation sequencing has transformed the field of oncology. Early successes in identifying and targeting oncogenic drivers of solid tumors have set the foundation for genomics-guided precision medicine; but, for hematological malignancies, the path to precision medicine is a lot more complex.

    Feb 8, 2019
  • Oxford Nanopore Launches cDNA Kits

    Bio-IT World News Brief  Oxford Nanopore has launched new ‘109’ cDNA Kits for its real-time, scalable sequencing technology.   The new kits provide high throughput while generating complete sequences of full-length cDNA strands, with a low input option of just 1 ng PolyA+ RNA.

    Feb 5, 2019
  • CRISPR's Gene Editing Toolbox Is Expanding

    Los Angeles Times | The scientists who developed the revolutionary gene-editing system known as CRISPR are improving it with new tools that make it work better.

    Feb 5, 2019
  • GA4GH Adds Seven Genomic Data Initiatives As New Driver Projects

    Bio-IT World News Brief | The Global Alliance for Genomics and Health (GA4GH) has named seven of the world’s leading genomic data initiatives as new Driver Projects for 2019.

    Feb 4, 2019
  • Collaboration And Machine Learning Key For 23andMe’s Drug Discovery Efforts

    Bio-IT World | 23andMe is at the forefront of a collaborative effort to forge partnerships with pharma companies and research institutes to improve drug discovery, as well as use resources to capitalize on the growth of personalized medicine.

    Jan 31, 2019